Navigation Links
BioMarin Announces Third Quarter 2010 Financial Results
Date:10/28/2010

t income is detailed in the table provided near the end of the press release.

GAAP net income for the nine months ended September 30, 2010 was $218.0 million ($1.74 per diluted share), compared to GAAP net loss of $5.2 million ($0.05 per diluted share) for the nine months ended September 30, 2009.  Non-GAAP net income was $23.4 million ($0.22 per diluted share) for the nine months ended September 30, 2010, compared to non-GAAP net income of $33.9 million ($0.33 per diluted share) for the nine months ended September 30, 2009.

As of September 30, 2010, BioMarin had cash, cash equivalents and short and long-term investments totaling $440.9 million, as compared to $455.4 million at the end of June 30, 2010.  

"In the third quarter, we saw strong commercial performance, despite being a seasonally weaker quarter.  During the quarter, based upon, among other things, our expectations to generate taxable income for the foreseeable future, we reversed most of our deferred tax asset valuation allowance which resulted in a one-time credit totaling $223.1 million," said Jean-Jacques Bienaime, Chief Executive Officer of BioMarin.  "Our pipeline has advanced tremendously over the last few months as highlighted at our recent R&D Day, and we are committed to investing in advancing the pipeline over the next two years to drive future growth.  We look forward to keeping you updated on the many clinical milestones expected in the coming year."

Net Product Revenue (in millions)Three Months Ended September 30,Nine Months Ended September 3020092010$ Change% Change20092010$ Change% ChangeNaglazyme (1) $

42.1$

51.7$

9.622.8%$

124.3$

147.5$

23.218.7%Kuvan (2) 21.726.24.520.7%54.172.118.033.3%Firdapse (3) −2.22.2N/A−3.43.4N/A(1)Changes in foreign currency rates, net of hedges, had a positive $0.1 million impact on Naglazyme sales in the three months ended September
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. BioMarin to Host a Research and Development Day on October 19th
2. BioMarin Appoints William Young and Kenneth Bate to Its Board of Directors
3. BioMarin to Present at the UBS Global Life Sciences Conference
4. BioMarin to Present at the Stifel Nicolaus Healthcare Conference
5. BioMarin Receives Orphan Drug Designation from the FDA for BMN-701 for the Treatment of Pompe Disease
6. BioMarin Acquires ZyStor Therapeutics, Inc.
7. BioMarin Initiates Phase 3b Study to Evaluate the Effects of Kuvan on Neurophychiatric Symptoms in Subjects with PKU
8. BioMarin to Acquire LEAD Therapeutics
9. BioMarin to Present at the Credit Suisse Healthcare Conference
10. BioMarin Announces Third Quarter 2009 Financial Results
11. BioMarin to Present at the Oppenheimer Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... NORWALK, Conn. , July 23, 2014 ... NeurologyTimes.com – a new online community and information ... them better manage and treat their patients with ... conditions, coupled with an aging population, necessitates greater access ... specific disorders.  Key statistics on neurological conditions include: ...
(Date:7/23/2014)... , July 23, 2014 Pharmavite LLC announced ... chief customer officer effective immediately. Toll recently served as ... and marketing, category management, private label and sales administration ... his new global role, Toll will expand his responsibilities ... planning. "Toll,s appointment to chief customer officer ...
(Date:7/23/2014)... DUBLIN , July 23, 2014 ... addition of the "Global Electrophysiology Ablation Catheters ... http://photos.prnewswire.com/prnh/20130307/600769 ... to remove or destroy faulty electrical pathways from ... rhythms (also known as cardiac arrhythmias). Cardiac arrhythmias ...
Breaking Medicine Technology:UBM Medica US Launches NeurologyTimes.com 2UBM Medica US Launches NeurologyTimes.com 3Global Electrophysiology Ablation Catheters Market 2014-2018: Key Vendors are Boston Scientific, Johnson & Johnson, Medtronic and St. Jude Medical 2Global Electrophysiology Ablation Catheters Market 2014-2018: Key Vendors are Boston Scientific, Johnson & Johnson, Medtronic and St. Jude Medical 3
... , , MOUNTAIN VIEW, Calif., Dec. 29 ... developing innovative, next-generation medical therapies to address unmet needs in ... Drug Application (NDA) has been submitted to the U.S. Food ... drug for the treatment of obesity, including weight loss and ...
... , , REDWOOD CITY, Calif., Dec. 28 Codexis, ... Form S-1 with the U.S. Securities and Exchange Commission ("SEC") relating ... stock. The shares of common stock to be sold in ... certain of its stockholders. , Credit Suisse Securities (USA) LLC and ...
Cached Medicine Technology:VIVUS Submits Qnexa(R) New Drug Application to the FDA for the Treatment of Obesity 2VIVUS Submits Qnexa(R) New Drug Application to the FDA for the Treatment of Obesity 3VIVUS Submits Qnexa(R) New Drug Application to the FDA for the Treatment of Obesity 4VIVUS Submits Qnexa(R) New Drug Application to the FDA for the Treatment of Obesity 5Codexis, Inc. Files Registration Statement for Proposed Initial Public Offering 2
(Date:7/23/2014)... CA (PRWEB) July 23, 2014 “Unlike ... will focus on developing your own unique gifts, talents ... techniques and clichéd sales verbiage, “says Ja Marr Brown. ... Your Sales Story?" which chronicles Brown’s transformation from nearly ... Person of The Year, winning every sales contest offered ...
(Date:7/23/2014)... (PRWEB) July 23, 2014 The puffiness ... diminished using non-surgical techniques, according to a new guide ... eyes serum sold in the U.S. is now available ... . , The complimentary guide that is now published ... struggle with under eye puffiness. While surgical techniques are ...
(Date:7/23/2014)... Edmond, Oklahoma (PRWEB) July 23, 2014 ... North America’s leading provider of in-home care for ... Healthy Longevity Webinar Series featuring experts in a ... upcoming webinar will feature licensed clinical social worker ... the most common causes of caregiver stress and ...
(Date:7/23/2014)... HealthDay Reporter WEDNESDAY, July 23, 2014 ... been exposed to some form of childhood trauma than their ... seems to apply solely to military men, not women. ... cause for concern, given that early childhood exposure to various ... population has been linked to a higher adult risk for ...
(Date:7/23/2014)... if a suspicious skin lesion is painful or itchy ... to be cancerous, according to a new study headed ... Dermatology at Temple University School of Medicine. , The ... July 23, 2014, found that nearly 36. 9 percent ... 28.2 percent involve pain. Non-melanoma skin cancers specifically, ...
Breaking Medicine News(10 mins):Health News:Using Your Story and Not Technique to Achieve Sales Success 2Health News:Puffy Eyes Serum Explored in Complimentary Guide Released at Consumer News Website 2Health News:Oklahoma Home Care Assistance Hosting Caregiver Mindfulness Webinar Tomorrow 2Health News:Oklahoma Home Care Assistance Hosting Caregiver Mindfulness Webinar Tomorrow 3Health News:Many U.S. Male Soldiers Had Troubled Childhoods, Study Finds 2Health News:Many U.S. Male Soldiers Had Troubled Childhoods, Study Finds 3Health News:Research led by Temple's chair of dermatology: Pain and itch may be signs of skin cancer 2
... Farm, South Africa, concluded that male circumcision could considerably ... the researchers studied the economical aspects of this approach ... new research is published in PLoS Medicine, and suggests ... in South Africa, mainly through savings on the cost ...
... that Health Care Workers (HCWs) in developing countries are particularly ... latent infection with tuberculosis, which is active. The infected ... ,One third of the world's population is ... most people, the bug causes no health problems and it ...
... a heart surgery years ago underwent the same procedure ... he is raring to get back to work after recuperating ... blood vessel called aorta, in his heart ,that was torn. ... surgical procedure for a condition called dissecting aortic aneurysm.As a ...
... study based on research in pregnant mice suggest that ... cruciferous vegetables during pregnancy// may show more resistance to ... in their adulthood. ,In this study, researchers ... discovered that a phytochemical administered in pregnant mice, help ...
... receive transfusions during heart bypass surgery have a higher ... their operation. ,In fact, this increased risk ... bypass patients are more likely than men to die ... more likely to receive blood during heart bypass operations, ...
... today welcomed the first formal agreement to deliver a ... the move as a win for patients and doctors ... the first organisation to sign up to deliver the ... rebates immediately after paying the doctor’s bill. ...
Cached Medicine News:Health News:Pioneer Heart Surgeon Faced the Scalpel at 98 2Health News:Pregnant Women- Eat Broccoli And Cabbage 2Health News:Blood Transfusions Raise Heart Patients’ Infection and Death Ris 2Health News:Blood Transfusions Raise Heart Patients’ Infection and Death Ris 3
... VALTRAC™ Single Use Biofragmentable Anastomosis Rings., ... end-to-side and side-to-side anastomosis., ,VALTRAC™ ... multiple intestinal anastomoses but not for ... may be used in any disease ...
... use instrument to create an automatic ... ,The PURSTRING™ 45 disposable instrument has ... and cardiac surgery for temporary and ... PURSTRING™ 65 disposable instrument has application ...
The Auto Suture™ EEA™ 34mm reusable stainless steel sizer has application in intestinal, colorectal and esophageal surgery to help evaluate the diameter of tubular structures....
The Auto Suture™ EEA™ reusable stainless steel sizer set has application in intestinal, colorectal and esophageal surgery to help evaluate the diameter of tubular structures....
Medicine Products: